Sotalol hydrochloride 240 MG Oral Tablet — RxCUI 904589
RxNorm drug concept · Semantic clinical drug
RxCUI 904589
Semantic clinical drug · SCD
● Current RxNorm concept 26 FDA products
35 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI904589
Official nameSotalol hydrochloride 240 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known assotalol HCl 240 MG Oral Tablet
FDA products mapped26
Package NDCs mapped35
Reported Medicaid activity (SDUD)42,875 prescriptions · 48 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Sotalol: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Sotalol treats life-threatening ventricular arrhythmias. Some products also help keep a normal rhythm in people with highly symptomatic atrial fibrillation or flutter. It has not b...
- Sotalol can cause dangerous rhythm problems, especially in the first days or after a dose increase. In the hospital your heart is monitored continuously and your kidney function is...
- Why do I have to start it in the hospital?
- No. Stopping suddenly can cause chest pain or even a heart attack, especially if you have heart disease. If you need to stop, your doctor will usually lower the dose over 1 to 2 we...
🕸️ Concept Web — How Sotalol hydrochloride 240 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Sotalol hydrochloride 240 MG Oral Tablet
RxCUI 904589 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Sotalol
9947IN -
Sotalol hydrochloride
7008PIN
-
Sotalol
-
Brand names 2
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Betapace
224909BN -
Sorine
284871BN
-
Betapace
-
Dose forms 17
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Sotalol Oral Tablet
373937SCDF -
Sotalol hydrochloride Oral Tablet
2648136SCDFP -
Sotalol Oral Product
1161104SCDG -
Sotalol Pill
1161105SCDG -
Sotalol hydrochloride Oral Product
2659339SCDGP -
Sotalol hydrochloride Pill
2660941SCDGP -
Sotalol Oral Tablet [Betapace]
367639SBDF -
Sotalol Oral Tablet [Sorine]
368661SBDF - +9 more in this family
-
Sotalol Oral Tablet
-
Clinical & branded drugs 5
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Sotalol hydrochloride 240 MG
904588SCDC -
Sotalol hydrochloride 240 MG Oral Tablet [Betapace]
904591SBD -
Sotalol hydrochloride 240 MG Oral Tablet [Sorine]
904593SBD -
Sotalol hydrochloride 240 MG [Betapace]
904590SBDC -
Sotalol hydrochloride 240 MG [Sorine]
904592SBDC
-
Sotalol hydrochloride 240 MG
Showing up to 8 concepts per family — 17 of 26 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Sotalol hydrochloride 240 MG
SCDC · 904588 -
Sotalol Oral Tablet
SCDF · 373937 -
Sotalol hydrochloride Oral Tablet
SCDFP · 2648136 -
Sotalol Oral Product
SCDG · 1161104 -
Sotalol Pill
SCDG · 1161105 -
Sotalol hydrochloride Oral Product
SCDGP · 2659339 -
Sotalol hydrochloride Pill
SCDGP · 2660941
Brand-Name Concepts
-
Sotalol hydrochloride 240 MG Oral Tablet [Betapace]
SBD · 904591 -
Sotalol hydrochloride 240 MG Oral Tablet [Sorine]
SBD · 904593 -
Sotalol hydrochloride 240 MG [Betapace]
SBDC · 904590 -
Sotalol hydrochloride 240 MG [Sorine]
SBDC · 904592 -
Sotalol Oral Tablet [Betapace]
SBDF · 367639 -
Sotalol Oral Tablet [Sorine]
SBDF · 368661 -
Sotalol hydrochloride Oral Tablet [Betapace]
SBDFP · 2657970 -
Sotalol hydrochloride Oral Tablet [Sorine]
SBDFP · 2658088 -
Betapace Oral Product
SBDG · 1172920 -
Betapace Pill
SBDG · 1172921
📦 FDA Products & Package NDCs
26 products · 35 package NDCs
35 package NDCs map to RxCUI 904589 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00093-1060-01 | 100 TABLET in 1 BOTTLE (0093-1060-01) | Sotalol Hydrochloride | Teva Pharmaceuticals USA, Inc. | 2000-05-05 |
| 00093-1061-01 | 100 TABLET in 1 BOTTLE (0093-1061-01) | Sotalol Hydrochloride | Teva Pharmaceuticals USA, Inc. | 2000-05-04 |
| 00093-1062-01 | 100 TABLET in 1 BOTTLE (0093-1062-01) | Sotalol Hydrochloride | Teva Pharmaceuticals USA, Inc. | 2000-05-05 |
| 00093-1063-01 | 100 TABLET in 1 BOTTLE (0093-1063-01) | Sotalol Hydrochloride | Teva Pharmaceuticals USA, Inc. | 2000-05-05 |
| 11788-0051-01 | 100 TABLET in 1 BOTTLE (11788-051-01) | SOTALOL HYDROCHLORIDE | AiPing Pharmaceutical, Inc. | 2025-11-01 |
| 11788-0052-01 | 100 TABLET in 1 BOTTLE (11788-052-01) | SOTALOL HYDROCHLORIDE | AiPing Pharmaceutical, Inc. | 2025-11-01 |
| 11788-0053-01 | 100 TABLET in 1 BOTTLE (11788-053-01) | SOTALOL HYDROCHLORIDE | AiPing Pharmaceutical, Inc. | 2025-11-01 |
| 11788-0054-01 | 100 TABLET in 1 BOTTLE (11788-054-01) | SOTALOL HYDROCHLORIDE | AiPing Pharmaceutical, Inc. | 2025-11-01 |
| 51655-0450-15 | 50 TABLET in 1 BOTTLE, PLASTIC (51655-450-15) | Sotalol Hydrochloride | Northwind Health Company, LLC | 2023-06-14 |
| 60429-0748-01 | 100 TABLET in 1 BOTTLE (60429-748-01) | Sotalol Hydrochloride | Golden State Medical Supply, Inc. | 2003-02-01 |
| 60505-0080-00 | 100 TABLET in 1 BOTTLE (60505-0080-0) | Sotalol Hydrochloride | Apotex Corp. | 2003-02-01 |
| 60505-0080-01 | 1000 TABLET in 1 BOTTLE (60505-0080-1) | Sotalol Hydrochloride | Apotex Corp. | 2003-02-01 |
| 60505-0081-00 | 100 TABLET in 1 BOTTLE (60505-0081-0) | Sotalol Hydrochloride | Apotex Corp. | 2003-02-01 |
| 60505-0081-01 | 1000 TABLET in 1 BOTTLE (60505-0081-1) | Sotalol Hydrochloride | Apotex Corp. | 2003-02-01 |
| 60505-0082-00 | 100 TABLET in 1 BOTTLE (60505-0082-0) | Sotalol Hydrochloride | Apotex Corp. | 2003-02-01 |
| 60505-0082-01 | 1000 TABLET in 1 BOTTLE (60505-0082-1) | Sotalol Hydrochloride | Apotex Corp. | 2003-02-01 |
| 60505-0159-00 | 100 TABLET in 1 BOTTLE (60505-0159-0) | Sotalol Hydrochloride | Apotex Corp. | 2003-02-01 |
| 60505-0159-01 | 1000 TABLET in 1 BOTTLE (60505-0159-1) | Sotalol Hydrochloride | Apotex Corp. | 2003-02-01 |
| 60505-0222-01 | 100 TABLET in 1 BOTTLE, PLASTIC (60505-0222-1) | Sotalol Hydrochloride | Apotex Corp. | 2003-09-09 |
| 60505-0222-02 | 1000 TABLET in 1 BOTTLE, PLASTIC (60505-0222-2) | Sotalol Hydrochloride | Apotex Corp. | 2003-09-09 |
| 60505-0223-01 | 100 TABLET in 1 BOTTLE, PLASTIC (60505-0223-1) | Sotalol Hydrochloride | Apotex Corp. | 2003-09-09 |
| 60505-0223-02 | 1000 TABLET in 1 BOTTLE, PLASTIC (60505-0223-2) | Sotalol Hydrochloride | Apotex Corp. | 2003-09-09 |
| 60505-0224-01 | 100 TABLET in 1 BOTTLE, PLASTIC (60505-0224-1) | Sotalol Hydrochloride | Apotex Corp. | 2003-09-09 |
| 60505-0224-02 | 1000 TABLET in 1 BOTTLE, PLASTIC (60505-0224-2) | Sotalol Hydrochloride | Apotex Corp. | 2003-09-09 |
| 69584-0841-10 | 100 TABLET in 1 BOTTLE (69584-841-10) | Sotalol Hydrochloride | Oxford Pharmaceuticals, LLC | 2020-07-24 |
| 69584-0841-50 | 500 TABLET in 1 BOTTLE (69584-841-50) | Sotalol Hydrochloride | Oxford Pharmaceuticals, LLC | 2020-07-24 |
| 69584-0842-10 | 100 TABLET in 1 BOTTLE (69584-842-10) | Sotalol Hydrochloride | Oxford Pharmaceuticals, LLC | 2020-07-24 |
| 69584-0842-30 | 300 TABLET in 1 BOTTLE (69584-842-30) | Sotalol Hydrochloride | Oxford Pharmaceuticals, LLC | 2020-07-24 |
| 69584-0843-10 | 100 TABLET in 1 BOTTLE (69584-843-10) | Sotalol Hydrochloride | Oxford Pharmaceuticals, LLC | 2020-07-24 |
| 69584-0844-10 | 100 TABLET in 1 BOTTLE (69584-844-10) | Sotalol Hydrochloride | Oxford Pharmaceuticals, LLC | 2020-07-24 |
| 72162-2586-01 | 100 TABLET in 1 BOTTLE (72162-2586-1) | SOTALOL HYDROCHLORIDE | Bryant Ranch Prepack | 2025-11-24 |
| 72789-0135-01 | 100 TABLET in 1 BOTTLE, PLASTIC (72789-135-01) | Sotalol Hydrochloride | PD-Rx Pharmaceuticals, Inc. | 2020-11-06 |
| 72789-0136-01 | 100 TABLET in 1 BOTTLE, PLASTIC (72789-136-01) | Sotalol Hydrochloride | PD-Rx Pharmaceuticals, Inc. | 2020-11-06 |
| 72789-0137-01 | 100 TABLET in 1 BOTTLE, PLASTIC (72789-137-01) | Sotalol Hydrochloride | PD-Rx Pharmaceuticals, Inc. | 2020-11-06 |
| 72789-0138-01 | 100 TABLET in 1 BOTTLE, PLASTIC (72789-138-01) | Sotalol Hydrochloride | PD-Rx Pharmaceuticals, Inc. | 2020-11-06 |
Observed labelers:
Apotex Corp. (14) ·
Oxford Pharmaceuticals, LLC (6) ·
AiPing Pharmaceutical, Inc. (4) ·
PD-Rx Pharmaceuticals, Inc. (4) ·
Teva Pharmaceuticals USA, Inc. (4) ·
Bryant Ranch Prepack (1)
· +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.